About 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide
1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide (PubChem CID 159729794) has the molecular formula C104H91N21O5S
and a molecular weight of 1747.08 g/mol. Its IUPAC name is 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide.
Frequently Asked Questions
What is the IUPAC name of 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide?
The IUPAC name of 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide (CID 159729794) is 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide.
What is the SMILES notation for 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide?
The canonical SMILES for 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide is CC(=O)c1ccc(C2N=C(c3cccc(C)n3)N(c3ccc4c(c3)OCO4)N2)cc1.Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1.Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1.Cc1cccc(C2=NCC=C2c2ccnc(OCc3cn(C)cn3)c2)n1.Cc1nc(-c2ccccc2)c(-c2ccncc2)o1.
What is the InChIKey of 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide?
The InChIKey is NBCCEBFNMUBNSQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H19N5S.C23H20N4O3.C21H21N5.C20H19N5O.C15H12N2O/c1-17-8-7-13-23(27-17)24-21(19-14-15-26-22-12-6-5-11-20(19)22)16-30(29-24)25(31)28-18-9-3-2-4-10-18;1-14-4-3-5-19(24-14)23-25-22(17-8-6-16(7-9-17)15(2)28)26-27(23)18-10-11-20-21(12-18)30-13-29-20;1-13-6-5-7-16(24-13)19-18(25-20(26-19)21(2,3)4)14-8-9-15-17(12-14)23-11-10-22-15;1-14-4-3-5-18(24-14)20-17(7-9-22-20)15-6-8-21-19(10-15)26-12-16-11-25(2)13-23-16;1-11-17-14(12-5-3-2-4-6-12)15(18-11)13-7-9-16-10-8-13/h2-16H,1H3,(H,28,31);3-12,22,26H,13H2,1-2H3;5-12H,1-4H3,(H,25,26);3-8,10-11,13H,9,12H2,1-2H3;2-10H,1H3.
What are the key properties of 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide?
1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide has a molecular weight of 1747.08 g/mol, XLogP of 20.89, 16 rotatable bonds, 3 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[2-(1,3-benzodioxol-5-yl)-3-(6-methyl-2-pyridinyl)-1,5-dihydro-1,2,4-triazol-5-yl]phenyl]ethanone;6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline;2-methyl-6-[4-[2-[(1-methylimidazol-4-yl)methoxy]-4-pyridinyl]-2H-pyrrol-5-yl]pyridine;2-methyl-4-phenyl-5-pyridin-4-yl-1,3-oxazole;3-(6-methyl-2-pyridinyl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide is sourced from PubChem (CID 159729794), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).